Capital Advisors Ltd’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Capital Advisors Ltd's ELV Position: Q2 2026 in Review
Capital Advisors Ltd increased its Elevance Health (ELV) stake by 0.4% in Q2 2026, buying an estimated $371 and bringing the position to 251 shares worth $97K. The position accounts for 0.01% of the portfolio, ranked #399.
Capital Advisors Ltd first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $135K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Capital Advisors Ltd held 251 shares of Elevance Health worth $97K as of Q2 2026.
- Capital Advisors Ltd bought 1 Elevance Health share in Q2 2026, an estimated $371.
- Elevance Health made up 0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #399 holding.
- Capital Advisors Ltd first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
- Capital Advisors Ltd's Elevance Health position peaked at $135K in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.